Table 1:
Patient Characteristics Based on Weight Loss at 6 Months
| Variables | < 5% WL 6-month | ≥ 5% WL 6-month | P-Value* | Total |
|---|---|---|---|---|
| Sample Size | N = 57 | N = 28 | N = 85 | |
| Age - Median (Q1, Q3) | 54 (30, 73) | 59.5 (37, 71) | 0.09 | 56 (30, 73) |
| Baseline BMI - Median (Q1, Q3) | 31.6 (26.2, 45.3) | 29.9 (26.2, 49.2) | 0.12 | 31.45 (26.2, 49.2) |
| Baseline Weight (lb) - Median (Q1, Q3) | 189.4 (151.9, 253.1) | 172.8 (138.7, 268.7) | 0.05 | 186.29 (138.7, 268.7) |
| Race - n (%) | ||||
| White | 40 (70.2) | 24 (85.7) | 0.18 | 64 (75.3) |
| Non-White | 17 (29.8) | 4 (14.3) | 21 (24.7) | |
| Menopause Status - n (%) | ||||
| Pre-Menopause | 15 (26.3) | 8 (28.6) | >0.99 | 23 (27.1) |
| Post-Menopause | 42 (73.7) | 20 (71.4) | 62 (72.9) | |
| Drinking - n (%) | ||||
| Less than 1 per month | 19 (36.5) | 7 (25) | 0.04 | 26 (32.5) |
| 1-3 per month | 7 (13.5) | 11 (39.3) | 18 (22.5) | |
| More than 3 per month | 26 (50) | 10 (35.7) | 36 (45) | |
| Unknown | 5 | 0 | 5 | |
| Smoking - n (%) | ||||
| Yes | 13 (25) | 11 (39.3) | 0.21 | 24 (30) |
| No | 39 (75) | 17 (60.7) | 56 (70) | |
| Unknown | 5 | 0 | 5 | |
| Prior Chemotherapy - n (%) | ||||
| No | 20 (35.1) | 19 (67.9) | 0.006 | 39 (45.9) |
| Yes | 37 (64.9) | 9 (32.1) | 46 (54.1) | |
| Hormone Therapy - n (%) | ||||
| None | 12 (21.1) | 5 (17.9) | 0.95 | 17 (20) |
| Tamoxifen | 22 (38.6) | 12 (42.9) | 34 (40) | |
| Aromatase inhibitor | 23 (40.4) | 11 (39.3) | 34 (40) | |
*
P value for Fisher’s exact test for differences in categorical measures and for the Wilcoxon rank sum test for differences in continuous measures